Results 11 to 20 of about 6,872,930 (361)

Mass Screening of Asymptomatic Persons for Severe Acute Respiratory Syndrome Coronavirus 2 Using Saliva. [PDF]

Clin Infect Dis, 2021
Coronavirus disease 2019 (COVID-19) has rapidly evolved to become a global pandemic, largely owing to the transmission of its causative virus through asymptomatic carriers.
Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Inao T, Sakamaki K, Iwasaki S, Hayasaka K, Sugita J, Nishida M, Fujisawa S, Teshima T.   +12 more
europepmc   +2 more sources

Mass Screening for Celiac Disease: The Autoimmunity Screening for Kids Study. [PDF]

Am J Gastroenterol, 2021
Introduction: The Autoimmunity Screening for Kids (ASK) study is a large scale pediatric screening study in Colorado for celiac disease (CD) and type 1 diabetes.
Stahl MG, Geno Rasmussen C, Dong F, Waugh K, Norris JM, Baxter J, Yu L, Steck AK, Frohnert BI, Liu E, Rewers MJ, ASK Study Group.   +11 more
europepmc   +2 more sources

Liquid chromatography–Tandem mass spectrometry in newborn screening laboratories [PDF]

International Journal of Neonatal Screening, 2022
Tandem mass spectrometry (MS/MS) is the most universal platform currently available for the analysis of enzymatic activities and biomarkers in dried blood spots (DBS) for applications in newborn screening (NBS).
Giugliani, Roberto, Gelb, M., Matern, Dietrich   +2 more
core   +2 more sources

Sputum testing as the new mass screening method for COVID-19 patients in India - A public health perspective [PDF]

International Journal of Preventive Medicine, 2022
In December 2019, an unusual form of pneumonia of unknown origin was identified in Wuhan and soon expanded into an intercontinental pandemic that affected nations all over the world. The unusual pneumonia was subsequently named COVID-19.
Sheikh Mohd Saleem, Sudip Bhattacharya
doaj   +2 more sources

Validation of a new mass screening tool for cognitive impairment: Cognitive Assessment for Dementia, iPad version

Clinical Interventions in Aging, 2013
Keiichi Onoda,1 Tsuyoshi Hamano,2 Yoko Nabika,1 Atsuo Aoyama,1 Hiroyuki Takayoshi,1 Tomonori Nakagawa,1 Masaki Ishihara,1 Shingo Mitaki,1 Takuya Yamaguchi,1 Hiroaki Oguro,1 Kuninori Shiwaku,3 Shuhei Yamaguchi1 1Department of Neurology, 2Center for ...
Onoda K, Hamano T, Nabika Y, Aoyama A, Takayoshi H, Nakagawa T, Ishihara M, Mitaki S, Yamaguchi T, Oguro H, Shiwaku K, Yamaguchi S   +11 more
doaj   +2 more sources

Sensitive and Robust LC-MS/MS Assay to Quantify 25-Hydroxyvitamin D in Leftover Protein Extract from Dried Blood Spots

International Journal of Neonatal Screening, 2021
Neonatal dried blood spots (DBS) provide a remarkable resource for biobanks. These microsamples can provide information related to the genetic correlates of disease and can be used to quantify a range of analytes, such as proteins and small molecules ...
Sanne Grundvad Boelt, Lars Melgaard, Marta Jadwiga Thorbek, Nadia Sara Jensen MacSween, John J. McGrath, Arieh S. Cohen   +5 more
doaj   +1 more source

Noninvasive and Point-of-Care Surface-Enhanced Raman Scattering (SERS)-Based Breathalyzer for Mass Screening of Coronavirus Disease 2019 (COVID-19) under 5 min

ACS Nano, 2022
Population-wide surveillance of COVID-19 requires tests to be quick and accurate to minimize community transmissions. The detection of breath volatile organic compounds presents a promising option for COVID-19 surveillance but is currently limited by ...
Shi Xuan Leong, Yong Xiang Leong, Emily Xi Tan, Howard Yi Fan Sim, Charlynn Sher Lin Koh, Yih Hong Lee, Carice Chong, L. Ng, J. Chen, Desmond Jin Cheng Pang, Lam Bang Thanh Nguyen, Siew Kheng Boong, Xuemei Han, Ya‐Chuan Kao, Y. Chua, Gia Chuong Phan‐Quang, I. Phang, H. K. Lee, M. Abdad, N. Tan, X. Ling   +20 more
semanticscholar   +1 more source

SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg

The Lancet Regional Health - Europe, 2021
Background To accompany the lifting of COVID-19 lockdown measures, Luxembourg implemented a mass screening (MS) programme. The first phase coincided with an early summer epidemic wave in 2020.
P. Wilmes, J. Zimmer, Jasmin Schulz, F. Glod, Lisa Veiber, Laurent Mombaerts, Bruno Rodrigues, A. Aalto, Jessica Pastore, C. Snoeck, M. Ollert, G. Fagherazzi, J. Mossong, Jorge Gonçalves, A. Skupin, U. Nehrbass   +15 more
semanticscholar   +1 more source

Controlling COVID-19 Pandemic: A Mass Screening Experience in Saudi Arabia

Frontiers in Public Health, 2021
A highly accelerating number of people around the world have been infected with novel Coronavirus disease 2019 (COVID-19). Mass screening programs were suggested by the World Health Organization (WHO) as an effective precautionary measure to contain the ...
Anas A. Khan, Hadil M. Alahdal, Reema Alotaibi, Hana Sonbol, R. Almaghrabi, Yousef M. Alsofayan, Saqer M. Althunayyan, Faisal Alsaif, S. Almudarra, Khaled I. Alabdulkareem, A. Assiri, Hani A. Jokhdar   +11 more
semanticscholar   +1 more source

Metabolic signature of the pathogenic 22q11.2 deletion identifies carriers and provides insight into systemic dysregulation

Translational Psychiatry, 2023
Large deletions at chromosome 22q11.2 are known to cause severe clinical conditions collectively known as 22q11.2 deletion syndrome. Notwithstanding the pathogenicity of these deletions, affected individuals are typically diagnosed in late childhood or ...
Julie Courraud, Francesco Russo, Gonçalo Espregueira Themudo, Susan Svane Laursen, Andrés Ingason, David M. Hougaard, Arieh S. Cohen, Thomas Werge, Madeleine Ernst   +8 more
doaj   +1 more source